Iloprost and exercise haemodynamics in heart failure with preserved ejection fraction—the ILO‐HOPE randomised controlled trial

British Journal of Clinical Pharmacology ◽

10.1111/bcp.14484 ◽

2020 ◽

Author(s):

Cho‐Kai Wu ◽

Jen‐Fang Cheng ◽

Chen‐Yu Huang ◽

Zheng‐Wei Chen ◽

Ssu‐Yuan Chen ◽

...

Keyword(s):

Heart Failure ◽

Randomised Controlled Trial ◽

Ejection Fraction ◽

Controlled Trial ◽

Preserved Ejection Fraction ◽

Randomised Controlled

Download Full-text

The Angiotensin Receptor Neprilysin Inhibitor LCZ696 in Heart Failure with Preserved Ejection Fraction: A Phase II Randomised-Controlled Trial

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2012.10.006 ◽

2012 ◽

Vol 18 (11) ◽

pp. 883 ◽

Cited By ~ 2

Author(s):

Scott D. Solomon ◽

Michael Zile ◽

Burkert Pieske ◽

Adriaan A. Voors ◽

Amil Shah ◽

...

Keyword(s):

Heart Failure ◽

Randomised Controlled Trial ◽

Ejection Fraction ◽

Phase Ii ◽

Controlled Trial ◽

Preserved Ejection Fraction ◽

Angiotensin Receptor ◽

Neprilysin Inhibitor ◽

Angiotensin Receptor Neprilysin Inhibitor ◽

Randomised Controlled

Download Full-text

Correction:The effect of luseogliflozin and alpha-glucosidase inhibitor on heart failure with preserved ejection fraction in diabetic patients: rationale and design of the MUSCAT-HF randomised controlled trial

BMJ Open ◽

10.1136/bmjopen-2018-026590corr1 ◽

2019 ◽

Vol 9 (5) ◽

pp. e026590corr1

Keyword(s):

Heart Failure ◽

Randomised Controlled Trial ◽

Ejection Fraction ◽

Controlled Trial ◽

Diabetic Patients ◽

Preserved Ejection Fraction ◽

Glucosidase Inhibitor ◽

Randomised Controlled ◽

Alpha Glucosidase

Download Full-text

Rehabilitation Enablement in Chronic Heart Failure—a facilitated self-care rehabilitation intervention in patients with heart failure with preserved ejection fraction (REACH-HFpEF) and their caregivers: rationale and protocol for a single-centre pilot randomised controlled trial

BMJ Open ◽

10.1136/bmjopen-2016-012853 ◽

2016 ◽

Vol 6 (10) ◽

pp. e012853 ◽

Cited By ~ 4

Author(s):

V Eyre ◽

C C Lang ◽

K Smith ◽

K Jolly ◽

R Davis ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Randomised Controlled Trial ◽

Ejection Fraction ◽

Controlled Trial ◽

Preserved Ejection Fraction ◽

Single Centre ◽

Pilot Randomised Controlled Trial ◽

Patients With Heart Failure ◽

Randomised Controlled

Download Full-text

Faculty Opinions recommendation of The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717955094.793462652 ◽

2012 ◽

Author(s):

Chim Lang

Keyword(s):

Heart Failure ◽

Randomised Controlled Trial ◽

Controlled Trial ◽

Preserved Ejection Fraction ◽

Phase 2 ◽

Angiotensin Receptor ◽

Double Blind ◽

Neprilysin Inhibitor ◽

Angiotensin Receptor Neprilysin Inhibitor ◽

Randomised Controlled

Download Full-text

IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial

BMJ Open ◽

10.1136/bmjopen-2016-012241 ◽

2016 ◽

Vol 6 (10) ◽

pp. e012241 ◽

Cited By ~ 10

Author(s):

Eduard Shantsila ◽

Ronnie Haynes ◽

Melanie Calvert ◽

James Fisher ◽

Paulus Kirchhof ◽

...

Keyword(s):

Atrial Fibrillation ◽

Randomised Controlled Trial ◽

Ejection Fraction ◽

Myocardial Fibrosis ◽

Exercise Tolerance ◽

Controlled Trial ◽

Preserved Ejection Fraction ◽

Randomised Controlled

Download Full-text

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

The Lancet ◽

10.1016/s0140-6736(12)61227-6 ◽

2012 ◽

Vol 380 (9851) ◽

pp. 1387-1395 ◽

Cited By ~ 637

Author(s):

Scott D Solomon ◽

Michael Zile ◽

Burkert Pieske ◽

Adriaan Voors ◽

Amil Shah ◽

...

Keyword(s):

Heart Failure ◽

Randomised Controlled Trial ◽

Controlled Trial ◽

Preserved Ejection Fraction ◽

Phase 2 ◽

Angiotensin Receptor ◽

Double Blind ◽

Neprilysin Inhibitor ◽

Angiotensin Receptor Neprilysin Inhibitor ◽

Randomised Controlled

Download Full-text

OUTSTEP‐HF: randomised controlled trial comparing short‐term effects of sacubitril/valsartan versus enalapril on daily physical activity in patients with chronic heart failure with reduced ejection fraction

European Journal of Heart Failure ◽

10.1002/ejhf.2076 ◽

2020 ◽

Author(s):

Massimo F. Piepoli ◽

Rizwan I. Hussain ◽

Josep Comin‐Colet ◽

Ramon Dosantos ◽

Philippe Ferber ◽

...

Keyword(s):

Physical Activity ◽

Heart Failure ◽

Chronic Heart Failure ◽

Randomised Controlled Trial ◽

Ejection Fraction ◽

Controlled Trial ◽

Daily Physical Activity ◽

Short Term ◽

Reduced Ejection Fraction ◽

Randomised Controlled

Download Full-text

Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial

The Lancet ◽

10.1016/s0140-6736(03)13801-9 ◽

2003 ◽

Vol 362 (9377) ◽

pp. 14-21 ◽

Cited By ~ 194

Author(s):

JGF Cleland ◽

DJ Pennell ◽

SG Ray ◽

AJ Coats ◽

PW Macfarlane ◽

...

Keyword(s):

Heart Failure ◽

Randomised Controlled Trial ◽

Ejection Fraction ◽

Myocardial Viability ◽

Controlled Trial ◽

Patients With Heart Failure ◽

Randomised Controlled

Download Full-text

P1474Automatic positive airway pressure for obstructive aleep apnoea in heart failure with reduced ejection fraction: A randomised controlled trial

European Heart Journal ◽

10.1093/eurheartj/ehx502.p1474 ◽

2017 ◽

Vol 38 (suppl_1) ◽

Author(s):

O. Oldenburg ◽

H. Fox ◽

B. Wellmann ◽

D. Horstkotte ◽

T. Bitter

Keyword(s):

Heart Failure ◽

Randomised Controlled Trial ◽

Ejection Fraction ◽

Airway Pressure ◽

Positive Airway Pressure ◽

Controlled Trial ◽

Reduced Ejection Fraction ◽

Randomised Controlled

Download Full-text

Faculty Opinions recommendation of The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717955094.793467314 ◽

2012 ◽

Author(s):

Jerome Fleg

Keyword(s):

Heart Failure ◽

Randomised Controlled Trial ◽

Controlled Trial ◽

Preserved Ejection Fraction ◽

Phase 2 ◽

Angiotensin Receptor ◽

Double Blind ◽

Neprilysin Inhibitor ◽

Angiotensin Receptor Neprilysin Inhibitor ◽

Randomised Controlled

Download Full-text